Los Angeles, CA (PRWEB) April 15, 2017
On December 19th, 2016 Paul Edalat and Olivia Karpinski each filed counterclaims against Bruce Cahill, Greg Cullen, Shane Scott, Ron Franco, Pharma Pak, Inc., and Edalat further against Leslie Harold Wood, Ludwig Jan Weimann, Ertan Ayidol, and Life Tech Global, LLC. Levied against the Counter-Claimants are various allegations of Breach of Fiduciary Duty, Fraud, Fraud by Concealment, Violation of Unfair Competition Law, Involuntary Dissolution, Unjust Enrichment, Discrimination, Sexual Harassment, Retaliation, Intentional Misrepresentation, and Negligent Misrepresentation. To date, all allegations have gone unopposed by the defendants.
It was first reported, appearing in the Los Angeles Times on October 24, 2016, in an article by Ben Brazil, in reference to the case filed in the United States District Court Central District Of California Southern Division, Case No. 8:16-cv-00686-AG-DFM, “UC Irvine Foundation trustee is the subject of a sexual harassment and wrongful-termination lawsuit by a former business employee that he says is retaliation for his own lawsuit accusing the employee and a shareholder of defrauding the company he ran.” Since this article’s release, approximately thirteen depositions have taken place, including that of Paul Edalat and Olivia Karpinski, Executives at Sentar Pharmaceuticals.
As reported, Mr. Cahill’s Attorney John Markham stated on the record that Ms. Karpinski's allegations of Mr. Cahill subjecting her to "sexually charged interactions" are unfounded and that Cahill is a "highly respected trustee who does a lot of charity work." According to Ms. Karpinski, and directly from her counter claim, she alleges that Mr. Cahill made diminutive comments and derogatory references toward women, in addition inappropriately touched Ms.Karpinski.
Additionally and within the December 19th claim, both Mr. Edalat and Ms. Karpinski state that after consulting with FDA counsel and former FDA investigators, they informed the Irvine Police Department in February of 2016 that they found THC and marijuana in their Irvine, CA facility. Through court documents and depositions it is alleged that Ludwig Weimann (Pharma Pak’s Chief Science Officer) had THC and CBD patches and sublingual pills made in the facility with Mr. Cahill's knowledge; he further admits that he possessed THC for what he describes as, “research purposes”
Bruce Cahill, a UC Irvine Foundation Trustee currently serves as Member of the UCIF Government Relations & Advocacy Committee, in addition to the Nomination & Board Development Committee.